BriaCell Therapeutics announced that its Bria-IMT cell therapy, plus an immune checkpoint inhibitor regimen, achieved ...

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

"Pell BMT Ltd.", a pioneering force in CAR-T (Chimeric Antigen Receptor T Cells) cell therapies in Taiwan, will attend the ...

In this study, the Cancer Research UK-funded scientists will establish the targets for the vaccine. They will find out which ...

Odisha's IMS and SUM Hospital performs first successful CAR-T cell therapy on Trupti from Mayurbhanj. Led by Dr. Priyanka ...

BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class ...

Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell ...

In this webinar, Christoph Herbel will discuss multiplexed spatial analyses that identify ovarian tumor antigens and CAR T ...

Panelists discuss how tarlatamab, a bispecific T-cell engager therapy, received accelerated approval for extensive-stage small cell lung cancer (SCLC) in May 2024, examining its mechanism of action, ...

In the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR ...